| Title | Diabetes and Metabolic Syndrome: Clinical Research and Reviews |
| Abbreviation | Diabetes Metab. Syndr.: Clin. Res. Rev. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Endocrinology, Diabetes and Metabolism (Q1); Internal Medicine (Q1); Medicine (miscellaneous) (Q1) |
| h-index | 71 |
| Overall Rank/Ranking | 2145 |
| SCImago Journal Rank (SJR) | 1.495 |
| Impact Score | 9.15 |
| Publisher | Elsevier BV |
| Country | Netherlands |
| ISSN | 18780334, 18714021 |
| Best Quartile | Q1 |
| Coverage History | 2007-2022 |
Diabetes and Metabolic Syndrome: Clinical Research and Reviews is a journal covering the technologies/fields/categories related to Endocrinology, Diabetes and Metabolism (Q1); Internal Medicine (Q1); Medicine (miscellaneous) (Q1). It is published by Elsevier BV. The overall rank of Diabetes and Metabolic Syndrome: Clinical Research and Reviews is 2145. According to SCImago Journal Rank (SJR), this journal is ranked 1.495. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 71. The best quartile for this journal is Q1.
The ISSN of Diabetes and Metabolic Syndrome: Clinical Research and Reviews journal is 18780334, 18714021. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Diabetes and Metabolic Syndrome: Clinical Research and Reviews is cited by a total of 8615 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Diabetes and Metabolic Syndrome: Clinical Research and Reviews is 9.15, which is computed in 2023 as per its definition. Diabetes and Metabolic Syndrome: Clinical Research and Reviews IF is increased by a factor of 0.62 and approximate percentage change is 7.27% when compared to preceding year 2021, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Diabetes and Metabolic Syndrome: Clinical Research and Reviews is 9.15. If the same upward trend persists, Impact IF may rise in 2023 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 9.15 |
| 2021 | 8.53 |
| 2020 | 2.53 |
| 2019 | 2.37 |
| 2018 | 2.03 |
| 2017 | 2.54 |
| 2016 | 2.63 |
| 2015 | 1.61 |
| 2014 | 1.50 |
Diabetes and Metabolic Syndrome: Clinical Research and Reviews has an h-index of 71. It means 71 articles of this journal have more than 71 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Diabetes and Metabolic Syndrome: Clinical Research and Reviews is 18780334, 18714021. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Diabetes and Metabolic Syndrome: Clinical Research and Reviews is 2145. According to SCImago Journal Rank (SJR), this journal is ranked 1.495. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 1.495 |
| 2021 | 1.587 |
| 2020 | 0.684 |
| 2019 | 0.672 |
| 2018 | 0.760 |
| 2017 | 0.876 |
| 2016 | 0.762 |
| 2015 | 0.611 |
| 2014 | 0.441 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 2145 |
| 2021 | 1909 |
| 2020 | 7302 |
| 2019 | 7271 |
| 2018 | 6256 |
| 2017 | 5216 |
| 2016 | 6133 |
| 2015 | 7757 |
| 2014 | 9908 |
Diabetes and Metabolic Syndrome: Clinical Research and Reviews is published by Elsevier BV. It's publishing house is located in Netherlands. Coverage history of this journal is as following: 2007-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Diabetes and Metabolic Syndrome: Clinical Research and Reviews is Diabetes Metab. Syndr.: Clin. Res. Rev.. This abbreviation ('Diabetes Metab. Syndr.: Clin. Res. Rev.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Endocrinology, Diabetes and Metabolism (Q1); Internal Medicine (Q1); Medicine (miscellaneous) (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Diabetes and Metabolic Syndrome: Clinical Research and Reviews latest impact IF is 9.15. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 9.15 (2022) and 1.50 (2014), respectively, in the last 9 years. Moreover, its average IS is 3.65 in the previous 9 years.
The Diabetes and Metabolic Syndrome: Clinical Research and Reviews has an SJR (SCImago Journal Rank) of 1.495, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 1.587 in 2021 and the lowest being 0.441 in 2014. Furthermore, the average SJR of the Diabetes and Metabolic Syndrome: Clinical Research and Reviews over the previous 9-year period stands at 3.65.
The latest h-index of the Diabetes and Metabolic Syndrome: Clinical Research and Reviews is 71.
The Diabetes and Metabolic Syndrome: Clinical Research and Reviews is published by the Elsevier BV, with its country of publication being the Netherlands.
The Diabetes and Metabolic Syndrome: Clinical Research and Reviews is currently ranked 2145 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 1909 in 2021 and its lowest position of 9908 in 2014.
The standard ISO4 abbreviation for the Diabetes and Metabolic Syndrome: Clinical Research and Reviews is Diabetes Metab. Syndr.: Clin. Res. Rev..
Diabetes and Metabolic Syndrome: Clinical Research and Reviews is classified as a journal that the Elsevier BV publishes.
The Diabetes and Metabolic Syndrome: Clinical Research and Reviews encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Diabetes and Metabolic Syndrome: Clinical Research and Reviews is assigned the following International Standard Serial Numbers (ISSN): 18780334, 18714021.
The best quartile for the Diabetes and Metabolic Syndrome: Clinical Research and Reviews is Q1 (2022).
The Diabetes and Metabolic Syndrome: Clinical Research and Reviews coverage history can be summarized as follows: 2007-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Proceedings of the Spring Technical Conference of the ASME Internal Combustion Engine Division | conference and proceedings | 17477 | 16 | 0.00 | |
| Journal of Education and Work | journal | 9268 | Brill Academic Publishers | 43 | 1.93 |
| Modern Language Journal | journal | 918 | Wiley-Blackwell | 103 | 3.89 |
| Studies in Continuing Education | journal | 6011 | Routledge | 38 | 2.81 |
| Tekstilec | trade journal | 19217 | Faculty of Natural Sciences and Engineering, Tekstilec | 14 | 0.73 |
| Sapporo Medical Journal | journal | 20468 | Cancer Research Institute, Sapporo Medical University | 3 | 0.00 |
| Canadian Journal of Mathematics | journal | 3905 | Canadian Mathematical Society | 43 | 0.79 |
| International Journal of Pest Management | journal | 13393 | Taylor and Francis Ltd. | 50 | 1.50 |
| Transactions on Embedded Computing Systems | journal | 6019 | Association for Computing Machinery (ACM) | 61 | 2.25 |
| Metascience | journal | 13645 | Springer Nature | 3 | 0.13 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 9.15 |
| 2021 | 8.53 |
| 2020 | 2.53 |
| 2019 | 2.37 |
| 2018 | 2.03 |
| 2017 | 2.54 |
| 2016 | 2.63 |
| 2015 | 1.61 |
| 2014 | 1.50 |
